Citations:NCP

English citations of NCP

2017, Dieckmann G, Goyal S, Hamrah P, “Neuropathic Corneal Pain: Approaches for Management”, in Ophthalmology, →DOI, page S34:
However, neuropathic corneal pain (NCP) is currently an ill-defined disease. Patients with NCP are extremely challenging to manage, and evidence-based clinical recommendations for the management of patients with NCP are scarce.

2020, Bayraktutar BN, Ozmen MC, Muzaaya N, Dieckmann G, Koseoglu ND, Müller RT, Cruzat A, Cavalcanti BM, Hamrah P, “Comparison of clinical characteristics of post-refractive surgery-related and post-herpetic neuropathic corneal pain”, in The Ocular Surface, →DOI, page 641:
Our knowledge about NCP, including underlying etiology, pathophysiological mechanism, severity of pain, its effect on quality of life (QoL), treatment and prognosis is very limited.

2022, Dermer H, Hwang J, Mittal R, Cohen AK, Galor A, “Corneal sub-basal nerve plexus microneuromas in individuals with and without dry eye”, in British Journal of Ophthalmology, →DOI, page 616:
Applied to the cornea, pain can arise at the level of the primary afferent corneal nerves and is thus labelled, neuropathic corneal pain (NCP), or it can arise from second-order and third-order neurons at the levels of the brainstem, thalamus or cortex.

2020 March, Hong-Zhi DuXiao-Ying HouYu-Huan MiaoBi-Sheng HuangDa-Hui Liuet al., “Traditional Chinese Medicine: an effective treatment for 2019 novel coronavirus pneumonia (NCP)”, in Chinese Journal of Natural Medicines, page 206:
Nowadays, TCM has exhibited decent effect in the fight against NCP. Therefore, it is convinced that Traditional Chinese Medicine is an effective treatment for 2019 novel coronavirus pneumonia.

2020 April, Ning Tang, Dengju Li, Xiong Wang, Ziyong Sun, “Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia”, in Journal of Thrombosis and Haemostasis, →DOI:
Since December 2019, novel coronavirus pneumonia (NCP) cases have emerged in Wuhan, China, and the 2019 novel coronavirus (2019‐nCoV) was confirmed as the cause of the NCP.

2021 January, Min ZhouDexiang YangYong ChenYanping XuJin-Fu Xuet al., “Deep learning for differentiating novel coronavirus pneumonia and influenza pneumonia”, in Annals of Translational Medicine, →DOI, page 111:
Chest computed tomography (CT) has been found to have high sensitivity in diagnosing novel coronavirus pneumonia (NCP) at the early stage, giving it an advantage over nucleic acid detection during the current pandemic.

2022, Bhagat, Shweta, and Yash Hada, “Mystery of Shedding Coronavirus in Tears of Patients Affected with COVID-19”, in ECS Transactions‎^[1], volume 107, page 17899:
From January 26 to February 9, 2020, 30 confirmed novel coronavirus pneumonia (NCP) patients were recruited for a prospective interventional case series investigation at zhejiang^[sic] university's first affiliated hospital.